Nanosphere
09:41 :
Nanosphere slides 15% on FDA setback -
BOSTON (MarketWatch) -- Nanosphere Inc. shares slid 15% early Tuesday to $1.88 after it announced that the U.S. Food and Drug Administration will not approve its Plavix Metabolism diagnostic test until the company submits additional ...
actualidad Nanosphere -